HIGHLY SENSITIVE AND CONTINUOUS PROTEIN-TYROSINE-PHOSPHATASE (PTPASE) TEST USING 6.8 DIFLUORO4-METHYL-UMBELLIFERYLPHOSPHA TE

Details for Australian Patent Application No. 2002361217 (hide)

Owner AVENTIS PHARMA DEUTSCHLAND GMBH

Inventors WELTE, Stefan; TENNAGELS, Norbert; PETRY, Stefan

Pub. Number AU-A-2002361217

PCT Number PCT/EP02/14755

PCT Pub. Number WO2003/056029

Priority 102 00 173.1 04.01.02 DE; 102 36 329.3 08.08.02 DE

Filing date 24 December 2002

Wipo publication date 15 July 2003

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 102 00 173.1 04.01.02 DE; 102 36 329.3 08.08.02 DE

4 September 2003 Application Open to Public Inspection

  Published as AU-A-2002361217

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

20 July 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002361218-Method for producing scopine esters

2002361216-Method for operating a plate system for stamping presses and connection element for carrying out said method